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Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset 
neurodegenerative disease characterized by degeneration 
and death of upper and lower motor neurons (MNs). 
Patients typically suffer from progressive motor weak-
ness, which starts focally and spreads through the body 
leading to paralysis and ultimately death within a few 
years of diagnosis. Although usually sporadic (without a 
family history), approximately 10% of ALS cases are 
familial (fALS) and of those, ~20% are caused by muta-
tions in the gene superoxide dismutase 1 (SOD1) (Kiernan 
and others 2012). More than 160 mutations in SOD1 have 
been identified in ALS sufferers, the majority of which 
are missense point mutations resulting in a dominant 
mode of inheritance. At least 75 of SOD1’s 154 amino 
acids have been reported as mutated in ALS and their 
positions are scattered throughout the five exons of the 
gene (Saccon and others 2013).
SOD1 is highly conserved throughout evolution 
(Wang and others 2006), ubiquitously expressed and 
makes up 1-2% of the total soluble protein in the central 
nervous system (Pardo and others 1995). Its primary 
function is thought to be as a cytosolic and mitochondrial 
antioxidant enzyme, converting superoxide to molecular 
oxygen and hydrogen peroxide; however, in yeast at 
least, less than 1% of total SOD1 is required to carry out 
this canonical function (Corson and others 1998; Reddi 
and Culotta 2013) leaving the question open as to whether 
SOD1 plays other equally important role(s), which might 
account for its abundance.
Many lines of evidence have led to the conclusion that 
mutations in SOD1 cause ALS via an as yet unidentified 
gain of function, although it has been proposed that a loss 
of function may also play a secondary role in disease, at 
least in some cases (Saccon and others 2013). A great 
number of cellular mechanisms has been implicated as 
potentially involved in SOD1-fALS pathogenesis, how-
ever, distinguishing cause from effect and identifying the 
critical processes remains challenging (Redler and 
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Abstract
The canonical role of superoxide dismutase 1 (SOD1) is as an antioxidant enzyme protecting the cell from 
reactive oxygen species toxicity. SOD1 was also the first gene in which mutations were found to be causative for 
the neurodegenerative disease amyotrophic lateral sclerosis (ALS), more than 20 years ago. ALS is a relentless and 
incurable mid-life onset disease, which starts with a progressive paralysis and usually leads to death within 3 to 5 years 
of diagnosis; in the majority of cases, the intellect appears to remain intact while the motor system degenerates. It 
rapidly became clear that when mutated SOD1 takes on a toxic gain of function in ALS. However, this novel function 
remains unknown and many cellular systems have been implicated in disease. Now it seems that SOD1 may play a 
rather larger role in the cell than originally realized, including as a key modulator of glucose signaling (at least so far 
in yeast) and in RNA binding. Here, we consider some of the new findings for SOD1 in health and disease, which may 
shed light on how single amino acid changes at sites throughout this protein can cause devastating neurodegeneration 
in the mammalian motor system.
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Dokholyan 2012). Here, we describe emerging themes in 
SOD1 biology that suggest this enzyme is involved in a 
widening array of cellular processes in both health and 
disease; this may shed new light on the pathogenesis of 
SOD1-ALS.
Transmission of SOD1
Some causative proteins for neurodegenerative diseases 
may have “prion-like” properties: the ability to sequester 
wildtype proteins and seed their aggregation or misfold-
ing, and to act as transmissible agents between cells 
(Polymenidou and Cleveland 2012) (Fig. 1). SOD1 dis-
plays prion-like properties in vitro and in cellular and 
now in animal models, which is particularly of interest 
for SOD1-fALS, given the focal start of ALS, the finding 
that motor neuron death is not cell-autonomous (e.g., see 
Ilieva and others 2009), and the implications for therapy 
to halt the spread of pathology. These findings are also 
important for a potential mechanism for spread, and pos-
sibly even pathogenesis in sporadic ALS (sALS), given 
the presence of aggregated SOD1 in sALS cases (Bosco 
and others 2010; Forsberg and others 2010; Grad and 
Cashman 2014).
SOD1 Seeded Aggregation In Vitro
In vitro assays measuring aggregation propensity show 
recombinant wildtype and ALS-mutant SOD1 can seed 
aggregation of themselves (self-seeding) and of each 
other (cross-seeding). Seeded amyloid fibrilization of 
SOD1 occurred at acidic pH and in the presence of a cha-
otrope (Chia and others 2010), and non-amyloid seeded 
fibrilization was seen at physiological pH (Hwang and 
others 2010). Spinal cord tissue homogenate from a 
SOD1G93A transgenic mouse (which models human ALS) 
was then shown to efficiently self- and cross-seed the 
amyloid fibrilization of recombinant wildtype and mutant 
SOD1 in vitro (Chia and others 2010). However, self- and 
cross-seeding does not, alone, indicate prion-like proper-
ties; the prion-like nature of a protein also comes from its 
ability to transmit between cells and indeed between 
organisms.
Transmission in Cell Models
Mutant SOD1 is found in medium from primary cultures 
of whole spinal cord and of astrocytes from SOD1-ALS 
transgenic mice (Basso and others 2013; Urushitani and 
Figure 1. Superoxide dismutase 1 (SOD1) may have prion-like properties. (A) Misfolded SOD1 within a cell could (B) sequester 
and misfold wildtype SOD1, ultimately producing aggregates, and (C) if secreted and taken up by neighboring cells could (D) 
cause a “chain reaction” of misfolding, aggregate formation, and transmission in a prion-like manner. The exact nature of this 
process—for example, the roles of monomers and aggregates—remains unknown.
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others 2006). Furthermore, mutant SOD1 is secreted in 
exosomes from primary astrocytes and neuronal-like sta-
ble cell lines, (Basso and others 2013; Grad and Cashman 
2014) (Fig. 2). Thus there is a mechanism for mutant 
SOD1 to get out of cells.
In terms of getting into cells, a range of recombinant 
forms of SOD1 (including wildtype and mutant, aggre-
gated and non-aggregated) are efficiently internalized by 
neuronal-like stable cell lines, via the non-selective 
mechanism, macropinocytosis (Grad and Cashman 2014; 
Münch and others 2011; Sundaramoorthy and others 
2013). Primary mouse spinal cord cultures and neuronal-
like cell lines also take in wildtype and mutant SOD1 via 
internalization of exosomes (Basso and others 2013; 
Grad and others 2014).
Once internalized, recombinant aggregated mutant 
SOD1 can self-seed aggregation of stably expressed 
mutant SOD1; this is sustained for up to 1 month and 
through multiple passages of a mouse neuroblastoma-
derived cell line, long after the exogenous seeds had 
apparently been cleared from the cells (Münch and others 
2011). Furthermore, recombinant mutant SOD1 (both 
aggregated and non-aggregated forms) can also cross-
seed endogenous wildtype SOD1—which can also be 
self-seeded by recombinant aggregated wildtype SOD1 
(Sundaramoorthy and others 2013).
Self-seeded aggregation of endogenous SOD1 by con-
ditioned medium has been shown in stable cell lines 
through multiple passages; this was blocked by both 
SOD1 knock-down and immuno-depletion of misfolded 
Figure 2. Mutant superoxide dismutase 1 (SOD1) may be transmitted from astrocytes to motor neurons, causing cell death. 
Mutant SOD1 is secreted in exosomes by astrocytes and may be taken in by motor neurons; propagation of misfolding may 
then proceed within the cell (see Fig. 1). Exposure of motor neurons to mutant SOD1 results in increased sodium channel 
permeability, induction of nitroxidative stress, hyperexcitability likely through dysregulation of AMPA receptors as well as sodium 
channel dysfunction and reduced viability.
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SOD1 in the medium (Grad and others 2011; Grad 
and Cashman 2014).
Transmission between Mouse Models
Recently, transmissibility of mutant SOD1 and motor 
neuron disease pathology between different transgenic 
mouse models appears to have been demonstrated. 
Spinal cord homogenates from SOD1G93A mice were 
injected into the spinal cords of different SOD1 trans-
genic models and motor neuron disease was induced in 
an otherwise unaffected transgenic animal expressing 
low levels of a different (SOD1 G85R) mutant SOD1 
protein (Ayers and others 2014). Remarkably, when tis-
sues from the induced mice were used to inoculate new 
SOD1G85R mice (“second passage homogenates”) dis-
ease onset was earlier in recipient animals, exactly as 
seen in prion disease models. Other data shows potential 
SOD1 “strains” akin to prion strains (Ayers and others 
2014). This article offers compelling data to indicate the 
physiological prion-like transmission of mutant SOD1 
and motor neuron disease pathology in vivo. Of note, 
one-third of the SOD1G85R mice inoculated with homog-
enates from wildtype SOD1 transgenic mice also devel-
oped the motor neuron degeneration phenotype, while 
self-seeding experiments in two other mutant SOD1 
transgenic lines failed to accelerate disease in these 
mice. Future work to identify whether a misfolded 
SOD1 species is both necessary and sufficient to induce 
disease, and to determine whether the phenomenon is 
applicable to other SOD1 variants will be needed.
Mutant SOD1 Expressing Glia Are 
Toxic to Motor Neurons
Data from transgenic mice with tissue specific/restricted 
expression of mutant SOD1 demonstrate that non-neuro-
nal cells are involved in the progression of disease-related 
phenotypes (reviewed in Ilieva and others 2009). In vitro 
experiments also clearly demonstrate the toxicity of 
mutant SOD1-expressing glia to motor neurons.
Astrocytes
Toxicity of astrocytes, to motor neurons has been dem-
onstrated by co-culture, and by the application of astro-
cyte conditioned medium (ACM) (Basso and others 
2013; Haidet-Phillips and others 2011; Meyer and oth-
ers 2014; Nagai and others 2007). Intriguingly, this 
interaction appears to be cell-type specific: mutant 
SOD1 expressing primary astrocytes reduced viability 
of both primary and embryonic stem cell-derived MNs 
in co-culture, but interneurons, GABAergic neurons, or 
dorsal root ganglion neurons were not affected. Mutant 
SOD1 fibroblasts, microglia, cortical neurons, or myo-
cytes were not toxic to co-cultured MNs (Nagai and 
others 2007).
Induction of nitroxidative stress and hyperexcitability 
has been proposed as a possible mode of astrocyte toxic-
ity to motor neurons: within 30 minutes of applying 
mutant SOD1 ACM, primary spinal MNs had increased 
excitability and increased sodium channel permeability; 
this exposure, followed by 4 days of culture with normal 
medium, was sufficient to cause ~50% MN death (Fritz 
and others 2013). ACM also produced an increase in 
intracellular nitroxidative stress in cultured MNs (Rojas 
and others 2014) (Fig. 2). Similarly, co-treatment with 
ACM and sodium channel blockers protected MNs from 
hyperexcitability, nitroxidative stress, and cell death, 
while antioxidants protected against nitroxidative stress 
and significantly improved MN survival, although their 
effect on sodium channel activity was not assessed (Fritz 
and others 2013; Rojas and others 2014). MNs co-cul-
tured with mutant SOD1 expressing astrocytes have been 
shown to have dysregulated AMPA receptor subunits and 
increased excitability (Van Damme and others 2007).
However, conversely, a separate study of mutant 
SOD1 transgenic mouse models found MNs with lowest 
basal excitability were the most vulnerable, and pharma-
cologically increasing MN activity reduced misfolded 
SOD1 pathology and markers of cellular stress while 
decreasing activity had the opposite, detrimental, effects 
(Saxena and others 2013).
The toxic factor released by astrocytes has not yet been 
identified and may well be/include mutant SOD1 because 
exosome depletion prevents ACM toxicity (Basso and 
others 2013). Interestingly, astrocytes from mutant TDP43 
transgenic mice, sALS and C9orf72 expansion patients 
have also been shown to cause MN toxicity by co-culture 
and by ACM (Haidet-Phillips and others 2011; Meyer and 
others 2014; Rojas and others 2014) suggesting some 
common toxic pathway in sALS and fALS.
Microglia
Activated microglia are thought to play an initially protec-
tive role in ALS, but then possibly become toxic due to 
increasing neuroinflammatory processes as disease 
advances (Lewis and others 2012). Microglia purified from 
mutant SOD1 mice are toxic to stem cell–derived human 
MNs and this toxicity appears to be dependent on prosta-
glandin signalling: activation of prostaglandin D2 (PGD2) 
receptor 1 (DP1) in wildtype mouse and human microglia 
prior to co-culture with MNs, induced significant MN tox-
icity. Conversely, pretreatment of mutant SOD1 mouse 
microglia with a pharmacological inactivator of DP1, or 
genetic ablation of DP1 expression, significantly attenuates 
toxicity to MNs (de Boer and others 2014).
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Expression of mutant SOD1 up-regulates PGD2 
receptor 1 (PTGDR) transcript levels in mouse and 
human microglia, and increases the release of PGD2 in 
rat microglia and astrocytes suggesting a possible interac-
tion between these glial cell types (Thonhoff and others 
2011). Nitroxidative stress may mediate microglial toxic-
ity to MNs; however, this appears to be specific to 
microglia prepared from symptomatic mutant SOD1 
expressing mice, so this effect is unlikely to be a primary 
cause of MN degeneration (Thonhoff and others 2011).
Protein Homeostasis
Unfolded Protein Response/Endoplasmic 
Reticulum Stress
The endoplasmic reticulum (ER) is a cellular compart-
ment in which post-translation protein processing, includ-
ing chaperone-assisted protein folding, is carried out. 
When the function of the ER is perturbed, ER stress acti-
vates two adaptive pathways: (1) the unfolded protein 
response (UPR) to refold misfolded proteins, and (2) 
ER-associated degradation (ERAD) to export misfolded 
proteins from the ER to the ubiquitin proteasome system 
(UPS) for degradation. Although ER stress pathways are 
initially protective responses, prolonged activation can 
lead to pro-apoptotic consequences.
The UPR has three main pathways (the activating tran-
scription factor 6 [ATF6], endoplasmic reticulum to 
nucleus signaling 1 (also known as inositol-requiring 
kinase 1) [IRE1], and eukaryotic translation initiation 
factor 2-α kinase 3 (also known as protein kinase RNA-
activated (PKR)-like ER kinase) [PERK] pathways) that 
are all activated in spinal MNs in SOD1-ALS mouse 
models (Walker and Atkin 2011). This activation appears 
to be an early, presymptomatic, event in SOD1G93A mice, 
with toxic consequences for the affected cells (Saxena 
and others 2009). Similarly, RNA profiles of MNs derived 
from a SOD1+/A4V fALS patient, show activation of ER 
stress and the UPR, compared with non-mutant isogenic 
controls (Kiskinis and others 2014).
Endoplasmic reticulum stress initially increases phos-
phorylation of eIF2α via PERK activation, which stalls 
protein synthesis (anti-apoptotic ER stress pathways). 
However, chronic ER stress activates GADD34 which 
dephosphorylates eIF2α, reinitiating protein translation 
in a pro-apoptotic pathway (Fig. 3). Blocking the dephos-
phorylation of p-eIF2α, increased survival of SOD1+/A4V 
MNs (Kiskinis and others 2014), and this could be due to 
stopping the pro-apoptotic action of GADD34. However, 
as the basal state of SOD1+/A4V MNs was of increased 
p-eIF2α these results are difficult to interpret.
Mutant SOD1G85R transgenic mice in which Perk is 
reduced (heterozygous knockout), have shortened disease 
duration and lifespan, perhaps because the UPR is over-
whelmed by misfolded mutant SOD1, whereas SOD1G85R 
transgenic mice in which the effect of PERK is increased 
by reduction of Gadd34 (heterozygous knockout), have 
an ameliorated disease and prolonged lifespan (Wang and 
others 2011; Wang and others 2014).
Mutant SOD1 has been implicated in the direct activa-
tion of ER stress through interaction with subunits of coa-
tomer coat protein II complex (COPII) in a transfected 
cell model and in mutant SOD1 transgenic mice as early 
as 10 days of age (Atkin and others 2014). COPII is 
essential for ER-Golgi transport, and expression of 
mutant SOD1 caused ER-Golgi transport disturbance 
before either the earliest markers for ER stress or aggre-
gate formation, implicating the interaction and its effect 
as an early upstream event in mutant SOD1 toxicity. 
Disrupting ER-Golgi transport in this way results in acti-
vation of ER stress responses (Fig. 4). In cellular models, 
co-expression of COPII subunits with mutant SOD1 sig-
nificantly reduced SOD1-induced apoptosis (Atkin and 
others, 2014).
SOD1 as an ER Stress Activating Zinc Sensor
Another recently proposed role for SOD1 is as a zinc sen-
sor, activating ER stress and up-regulating zinc transport-
ers by binding to Derlin1 in zinc-deficient conditions 
(Homma and others 2013). Derlin1 is an ERAD protein 
involved in export of misfolded proteins from the ER to 
the UPS. Under conditions of zinc depletion SOD1, 
which is a copper/zinc dependent enzyme, binds Derlin1 
at a normally hidden Derlin1 binding region, and the 
resulting dysfunction of both Derlin1 and the ERAD pro-
cess causes a build-up of misfolded protein in the ER and 
elicits ER stress (Fig. 5). ATF6, a transcription factor acti-
vated by ER stress, as well as up-regulating ER chaper-
ones, also promotes transcription of the zinc transporter 
ZIP14, which may act to restore intracellular zinc levels 
(Homma and others 2013).
SOD1 mutation in ALS may result in constitutive 
exposure of the Derlin1 binding region and chronic ER 
stress and ERAD dysfunction. Mutant SOD1 activates 
ER stress and the IRE1-ASK1 pro-apoptotic pathway in a 
Derlin1 binding-dependent manner (Nishitoh and others 
2008); further, of 132 ALS associated SOD1 mutations, 
124 co-immunoprecipitated with Derlin1 in transfected 
HEK cells (Fujisawa and others 2012). The mutants 
which did not co-precipitate with Derlin1 also failed to 
activate ER stress and were less toxic in cellular assays 
(Fujisawa and others 2012). In a SOD1G93A transgenic 
mouse model of ALS, knocking-out Ask1 improved sur-
vival and reduced MN death, showing that this pathway 
is also important in vivo, however, age at disease onset 
was unchanged (Nishitoh and others 2008).
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Motor neurons may have an increased basal level of 
ER stress as compared with other neuronal and non-neu-
ronal cell types; this difference might be a source of the 
selective vulnerability of MNs in ALS (Kiskinis and oth-
ers 2014) and might also make them more susceptible to 
perturbation of Derlin1 function by mutant SOD1.
Autophagy
The autophagy pathway for protein clearance has been 
implicated as dysfunctional in sALS and fALS patients 
(unidentified genotypes) and transgenic mouse models of 
SOD1-fALS (Hetz and others 2009, and reviewed in 
Song and others 2012). Pharmacological and genetic 
manipulation of autophagy pathways in SOD1-fALS 
mice and Caenorhabditis elegans models has resulted in 
conflicting findings suggesting both protective and toxic 
roles for autophagy (Hetz and others 2009; Li and others 
2013; Song and others 2012; Zhang and others 2011; 
Nassif and others 2014).
A direct role for mutant SOD1 in abnormal autoph-
agy is suggested as, when overexpressed in a neuronal-
like cell line, mutant SOD1 was found to co-precipitate 
with beclin 1 (BECN1), an autophagy activator, and 
with BCL2L1, a suppresser of BECN1 activity, whereas 
wildtype SOD1 only precipitated with BCL2L1 (Nassif 
and others 2014). The BECN1–BCL2L1 complex was 
weakened by co-expression with mutant SOD1, sug-
gesting mutant SOD1 may activate autophagy by releas-
ing BECN1 from the suppression of BCL2L1. However, 
Figure 3. Mutant superoxide dismutase 1 (SOD1) may cause chronic activation of endoplasmic reticulum (ER) stress. 
Acute anti-apoptotic and chronic pro-apoptotic ER stress pathways: (A) during acute activation of ER stress the three signal 
transduction pathways (the PERK, ATF6, and IRE1 pathways) mediate the unfolded protein response. PERK, ATF6, and IRE1 
proteins are associated with BiP (binding immunoglobulin protein). (B) However, if there is chronic activation of the ER stress 
PERK, ATF6, and IRE1 dissociate from BiP causing the activation of pro-apoptotic pathways. GADD34 is activated in the PERK 
pathway, promoting the dephosphorylation of p-elF2α and the reinitiation of protein synthesis. Chronic activation of ER stress, 
may mediate the unfolded protein response (UPR) and the ER-associated degradation (ERAD) mechanism.
Bunton-Stasyshyn and others 7
the effect of wildtype SOD1, or any other co-expressed 
protein, on the BECN1-BCL2L1 complex was not 
assessed, therefore it is not possible to attribute the 
effect specifically to mutant SOD1 rather than increased 
protein expression per se. The activation of autophagy 
by mutant SOD1 could also be a downstream conse-
quence of early effects on axonal transport and ER stress 
and ERAD (Hetz and others 2009; Zhang and others 
2007).
Other Emerging Roles for SOD1
Several causative “ALS genes” encode RNA binding 
proteins, and this has highlighted how disruption of 
processes involving RNA may play a primary role in the 
pathogenesis of the disease. Among these proteins, 
TDP43 and FUS are to date the most studied (Ling and 
others 2014; Nassif and others 2014). However, recent 
findings also point to a potential role of SOD1 in nucleic 
acid metabolism, as below.
SOD1 as a Transcription Factor
Although this is not their best characterized role, both 
TDP43 and FUS have been shown to act as transcription 
factors and, similarly, recent evidence has shown that 
SOD1 can regulate transcription in response to oxidative 
stress stimuli by moving into the nucleus and binding to 
Figure 4. Mutant superoxide dismutase 1 (SOD1) activates endoplasmic reticulum (ER) stress by disrupting ER-Golgi trafficking 
through binding to coatomer coat protein II complex (COPII). (A) In normal conditions, COPII transports normal and misfolded 
proteins from the ER to the Golgi (only misfolded proteins are show in the figure) but (B) when mutant SOD1 is present, it interacts 
with a COPII subunit disrupting ER-Golgi trafficking resulting in a buildup of misfolded proteins in the ER, leading to ER stress.
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promoters to regulate the expression of oxidative resis-
tance genes (Hu and others 2009; Tsang and others 2014).
SOD1 as an RNA Binding Protein
TDP43 (Transactive response DNA Binding protein 
43kDa) and FUS (Fused in Sarcoma) are involved in 
mRNA splicing, miRNA biogenesis, and mRNA stabili-
zation and transport (Ling and others 2014). Whilst evi-
dence of a role for SOD1 in the former two is still lacking, 
mutant SOD1 can bind mRNAs and play a role in their 
stabilization (Lu and others 2007; Lu and others 2009; 
Chen and others 2014). Wildtype SOD1 has further been 
shown to interact with TDP43, suggesting a potential 
common action in the regulation of specific RNA stabil-
ity (Volkening and others 2009).
Mutant SOD1 binds sequence elements within the 3′ 
UTR of VEGF (Vascular Endothelial Growth Factor) 
mRNA and forms complexes with other ribonucleopro-
teins such as TIAR and HuR. These interactions, which 
are specific to mutant SOD1, negatively affect levels of 
VEGF mRNA, which is a neuroprotective factor for 
motor neurons (Lu and others 2007; Lu and others 2009). 
Similarly, mutant SOD1 has been shown to bind the 3′ 
UTR of the neurofilament light chain (NFL) mRNA and 
negatively affect its stability. In an induce Pluripotential 
Stem Cell-derived cell model of ALS this reduction of 
NFL mRNA level mediates axonal degeneration, which 
could be a critical first step in ALS (Chen and others 
2014).
SOD1 as a Signaling Molecule
SOD1 and Cell Metabolic State Signaling. Using yeast and 
human cell lines Reddi and Culotta (2013) identified a 
new role in cellular metabolism for SOD1: to integrate 
signals from oxygen and glucose in order to repress res-
piration within cells. In the mechanism proposed SOD1 
binds the casein kinase gamma homologues Yck1p and 
Yck2p preventing their degradation via its enzymatic 
activity (Fig. 6). This results in repression of aerobic res-
piration and promotion of aerobic fermentation. Without 
SOD1, Yck1p and Yck2p are degraded, resulting in aero-
bic respiration. This finding gives insight into how rap-
idly proliferating cells may favor anaerobic glycolysis. 
Although effects in neurons remain to be determined the 
authors note the link between this signaling pathway and 
responses to hypoxia, a toxic state for motor neurons 
Figure 5. Superoxide dismutase 1 (SOD1) as an endoplasmic reticulum (ER) stress activating zinc sensor. (A) Under normal 
conditions wildtype SOD1 does not bind Derlin1, allowing export of misfolded proteins to the ubiquitin proteasome system 
(UPS). The three ER stress signal transducers PERK, ATF6, and IRE1 remain inactive and associated with binding immunoglobulin 
protein (BiP). (B) When mutant and/or in conditions of zinc depletion SOD1 assumes a mutant-like conformation exposing a 
binding site for Derlin1. The SOD1-Derlin1 interaction causes an accumulation of misfolded proteins which sequester BiP away 
from PERK, ATF6, and IRE1, activating the homeostatic ER stress response. Therefore, mutation of SOD1 in amyotrophic lateral 
sclerosis (ALS) may lead to constitutive Derlin1–SOD1 binding and ER stress activation.
Bunton-Stasyshyn and others 9
(Reddi and Culotta 2013). It is also interesting to note 
that a de novo mutation in casein kinase 1 gamma 3 
(CSNK1G3) was recently identified as a potential ALS 
risk factor (Chesi and others 2014) and, in a yeast screen 
YCK2, a homologue of the human casein kinase 1 gamma 
2, was identified as an enhancer of TDP43 toxicity (Kim 
and others 2014), offering hints that the putative interac-
tion between SOD1 and casein kinase 1 gamma could be 
relevant to ALS.
Conclusions and Outstanding 
Questions
In ALS, SOD1 takes on a toxic unknown gain of function. 
However, as with many proteins involved in neurodegen-
erative disease, it is still not clear what the normal func-
tions are for SOD1, and which cellular pathways rely on 
this protein. We know that it is abundant and ubiquitous, 
but protein levels appear to be far above what would be 
required solely for its role as an antioxidant in the cytosol.
New functions are now coming to light, and intrigu-
ingly—given the roles of other causative ALS genes—
SOD1 is involved in RNA metabolism, including acting 
as a nuclear transcription factor, and in metabolic signal-
ing. Almost certainly there is much more to be discovered 
about SOD1 function in the normal situation, as well as in 
ALS, where there are interesting links and converging 
themes involving excitotoxicity (AMPA receptors, 
sodium channel activation) and ER stress, as well as cell 
specific effects from astrocytes and microglia.
Study of these functions present new opportunities for 
badly needed therapeutics to modulate disease progres-
sion in SOD1-fALS, and possibly even sALS, perhaps in 
combination with anti-sense oligonucleotide therapies 
(Musarò 2013; Yang and others 2013). However, until we 
have a considerably better understanding of SOD1 func-
tions, much about this small protein remains enigmatic.
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